| 注册
首页|期刊导航|传统医学研究(英文版)|Integrated UHPLC-MS and network pharmacology to explore the active constituents and pharmacological mechanisms of Shenzao dripping pills against coronary heart disease

Integrated UHPLC-MS and network pharmacology to explore the active constituents and pharmacological mechanisms of Shenzao dripping pills against coronary heart disease

Tao Hu Ke-Ning Zheng Jia-Yin Liang Dan Tang Lu-Yong Zhang Ming-Hua Xian Shu-Mei Wang

传统医学研究(英文版)2022,Vol.7Issue(3):68-80,13.
传统医学研究(英文版)2022,Vol.7Issue(3):68-80,13.

Integrated UHPLC-MS and network pharmacology to explore the active constituents and pharmacological mechanisms of Shenzao dripping pills against coronary heart disease

Integrated UHPLC-MS and network pharmacology to explore the active constituents and pharmacological mechanisms of Shenzao dripping pills against coronary heart disease

Tao Hu 1Ke-Ning Zheng 2Jia-Yin Liang 3Dan Tang 1Lu-Yong Zhang 2Ming-Hua Xian 3Shu-Mei Wang1

作者信息

  • 1. Key Laboratory of Digital Quality Evaluation of Chinese Materia Medica of State Administration of Traditional Chinese Medicine,Guangdong Pharmaceutical University,Guangzhou 510006,China
  • 2. Engineering&Technology Research Center for Chinese Materia Medica Quality of the Universities of Guangdong Province,Guangzhou 510006,China
  • 3. School of Traditional Chinese Medicine,Guangdong Pharmaceutical University,Guangzhou 510006,China
  • 折叠

摘要

关键词

Shenzao dripping pills/coronary heart disease/chemical constituents/network pharmacology/molecular docking

Key words

Shenzao dripping pills/coronary heart disease/chemical constituents/network pharmacology/molecular docking

引用本文复制引用

Tao Hu,Ke-Ning Zheng,Jia-Yin Liang,Dan Tang,Lu-Yong Zhang,Ming-Hua Xian,Shu-Mei Wang..Integrated UHPLC-MS and network pharmacology to explore the active constituents and pharmacological mechanisms of Shenzao dripping pills against coronary heart disease[J].传统医学研究(英文版),2022,7(3):68-80,13.

基金项目

This work was supported by the Project of the Science and Technology Plan Project of Guangzhou(No.201803010115),the National Natural Science Foundation of China(No.82173972),and the National Major"Significant New Drugs Development"during the Thirteenth Five-Year Plan Period(No.2017ZX09301077).Technology Funds were obtained from the Key Unit of Chinese Medicine Digitalization Quality Evaluation of State Administration of Traditional Chinese Medicine.We thank Hai-Bin Luo from Sun Yat-sen University for technical assistance in SYBYL.We thank Wenxing Language Editing Co.Ltd.for editing the English text of a draft of this manuscript. (No.201803010115)

传统医学研究(英文版)

2413-3973

访问量0
|
下载量0
段落导航相关论文